Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haijiao Yan

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Oncotarget|October 21, 2015
MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathwayWei Zhou, Yongfeng Li, Shanmiao Gou, et al.
Human Gene Therapy|June 30, 2010
MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cellsHaijiao Yan, Jiangxue Wu, Wensong Liu, et al.
Digestive Diseases and Sciences|March 19, 2026
PODXL2 Promotes Cholangiocarcinoma Progression via Interactions with Ezrin and Activation of the MAPK/ERK1/2 and PI3K/AKT Signaling PathwaysYu Meng, Ye Zhang, Fang Wei, et al.
Plos One|August 31, 2011
Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/OxaliplatinJingting Jiang, Xiao Zheng, Xiao Xu, et al.
Cell Death & Disease|October 27, 2017
MiR-629 promotes human pancreatic cancer progression by targeting FOXO3Haijiao Yan, Qing Li, Jun Wu, et al.
Plos One|May 17, 2011
Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinomaYufang Zuo, Jiangxue Wu, Zumin Xu, et al.
Journal of Oncology|August 16, 2021
m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1Wenjie Zhou, Qingying Xian, Qi Wang, et al.
Translational Cancer Research|January 16, 2025
Safety and efficacy of mecapegfilgrastim in preventing neutropenia in patients with head and neck cancer: a multicenter, prospective, observational, real-world studyGang Cheng, Yong Chen, Nong Xu, et al.
Annals of Translational Medicine|June 24, 2021
Prophylaxis of neutropenia with mecapegfilgrastim in patients with non-myeloid malignancies: a real-world studyJun Ma, Huiqiang Huang, Peifen Fu, et al.
Immunity, Inflammation and Disease|August 6, 2024
A multicenter, prospective, non-interventional real-world study to assess the effectiveness of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal cancerChenyu Mao, Ye He, Nong Xu, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Oncotarget|October 21, 2015
MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathwayWei Zhou, Yongfeng Li, Shanmiao Gou, et al.
Human Gene Therapy|June 30, 2010
MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cellsHaijiao Yan, Jiangxue Wu, Wensong Liu, et al.
Digestive Diseases and Sciences|March 19, 2026
PODXL2 Promotes Cholangiocarcinoma Progression via Interactions with Ezrin and Activation of the MAPK/ERK1/2 and PI3K/AKT Signaling PathwaysYu Meng, Ye Zhang, Fang Wei, et al.
Plos One|August 31, 2011
Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/OxaliplatinJingting Jiang, Xiao Zheng, Xiao Xu, et al.
Cell Death & Disease|October 27, 2017
MiR-629 promotes human pancreatic cancer progression by targeting FOXO3Haijiao Yan, Qing Li, Jun Wu, et al.
Plos One|May 17, 2011
Minicircle-oriP-IFNγ: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinomaYufang Zuo, Jiangxue Wu, Zumin Xu, et al.
Journal of Oncology|August 16, 2021
m6A Methyltransferase 3 Promotes the Proliferation and Migration of Gastric Cancer Cells through the m6A Modification of YAP1Wenjie Zhou, Qingying Xian, Qi Wang, et al.
Translational Cancer Research|January 16, 2025
Safety and efficacy of mecapegfilgrastim in preventing neutropenia in patients with head and neck cancer: a multicenter, prospective, observational, real-world studyGang Cheng, Yong Chen, Nong Xu, et al.
Annals of Translational Medicine|June 24, 2021
Prophylaxis of neutropenia with mecapegfilgrastim in patients with non-myeloid malignancies: a real-world studyJun Ma, Huiqiang Huang, Peifen Fu, et al.
Immunity, Inflammation and Disease|August 6, 2024
A multicenter, prospective, non-interventional real-world study to assess the effectiveness of mecapegfilgrastim in preventing neutropenia in patients with gastrointestinal cancerChenyu Mao, Ye He, Nong Xu, et al.
Pageof 3